| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Commercial Officer
1 company
Jeffrey Del Carmen is Chief Commercial Officer at CPRX. Jeffrey Del Carmen's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider.
Historically, Jeffrey Del Carmen's trades have earned a below-average insider score of 43/100 across 6 rated trades. Over a 12-month horizon, 40.0% of those trades were profitable, with an average 12-month return of -12.7%.
Jeffrey Del Carmen has 19 Form 4 filings on record from November 2022 to December 2025, all as Chief Commercial Officer at Catalyst Pharmaceuticals (CPRX), 2022–2025.
The 43 reported transactions were 16 option exercises, 10 tax withholdings, 9 open-market sales and 8 option or other derivative awards.
Counted by filing, the open-market trades come to no purchases and 6 sales worth about $4.6M.
The largest open-market sale was 139,017 shares of CPRX at an average $16.12 on November 11, 2022, about $2.2M. Twelve months later CPRX was down 12%.
None of the 4 sales since April 2023 was marked as made under a Rule 10b5-1 trading plan.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 26, 2025 | CPRX Catalyst Pharmaceuticals, Inc. | Chief Commercial Officer | Sale+OE | 10,983 | $23.33 | $256,244.37 | -73.5% | +3.2% | - | |
| Mar 3, 2025 | CPRX Catalyst Pharmaceuticals, Inc. | Chief Commercial Officer | Sell | 30,423 | $22.89 | $696,382.47 | -100% | +11.6% | +7.3% | |
| Aug 9, 2024 | CPRX Catalyst Pharmaceuticals, Inc. | Chief Commercial Officer | Sale+OE | 36,058 | $18.42 | $664,309.52 | -74.5% | +25.8% | +7.5% | |
| Jun 7, 2024 | CPRX Catalyst Pharmaceuticals, Inc. | Chief Commercial Officer | Sell | 7,541 | $16.07 | $121,183.87 | -29.0% | +26.9% | +65.6% | |
| Mar 29, 2023 | CPRX Catalyst Pharmaceuticals, Inc. | Chief Commercial Officer | Sale+OE | 40,000 | $16.70 | $667,809.83 | -84.1% | -21.5% | -4.7% | |
| Nov 11, 2022 | CPRX Catalyst Pharmaceuticals, Inc. | Chief Commercial Officer | Sale+OE | 139,017 | $16.12 | $2,241,381.84 | - | +5.7% | -12.3% |